High‐mobility group box 1 released by autophagic cancer‐associated fibroblasts maintains the stemness of luminal breast cancer cells

Cancer stem cells/cancer‐initiating cells (CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis. Cancer‐associated fibroblasts (CAFs) are major components of the niche of breast cancer‐initiating cells (BCICs), and their interactions may profoundly...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of pathology Vol. 243; no. 3; pp. 376 - 389
Main Authors Zhao, Xi‐Long, Lin, Yong, Jiang, Jun, Tang, Zhuo, Yang, Shuai, Lu, Lu, Liang, Yan, Liu, Xue, Tan, Jiao, Hu, Xu‐Gang, Niu, Qin, Fu, Wen‐Juan, Yan, Ze‐Xuan, Guo, De‐Yu, Ping, Yi‐Fang, Wang, Ji Ming, Zhang, Xia, Kung, Hsiang‐Fu, Bian, Xiu‐Wu, Yao, Xiao‐Hong
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.11.2017
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cancer stem cells/cancer‐initiating cells (CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis. Cancer‐associated fibroblasts (CAFs) are major components of the niche of breast cancer‐initiating cells (BCICs), and their interactions may profoundly affect breast cancer progression. Autophagy has been considered to be a critical process for CIC maintenance, but whether it is involved in the cross‐talk between CAFs and CICs to affect tumourigenesis and pathological significance has not been determined. In this study, we found that the presence of CAFs containing high levels of microtubule‐associated protein 1 light chain 3 (LC3II), a marker of autophagosomes, was associated with more aggressive luminal human breast cancer. CAFs in human luminal breast cancer tissues with high autophagy activity enriched BCICs with increased tumourigenicity. Mechanistically, autophagic CAFs released high‐mobility group box 1 (HMGB1), which activated its receptor, Toll‐like receptor (TLR) 4, expressed by luminal breast cancer cells, to enhance their stemness and tumourigenicity. Furthermore, immunohistochemistry of 180 luminal breast cancers revealed that high LC3II/TLR4 levels predicted an increased relapse rate and a poorer prognosis. Our findings demonstrate that autophagic CAFs play a critical role in promoting the progression of luminal breast cancer through an HMGB1–TLR4 axis, and that both autophagy in CAFs and TLR4 on breast cancer cells constitute potential therapeutic targets. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
AbstractList Cancer stem cells/cancer‐initiating cells (CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis. Cancer‐associated fibroblasts (CAFs) are major components of the niche of breast cancer‐initiating cells (BCICs), and their interactions may profoundly affect breast cancer progression. Autophagy has been considered to be a critical process for CIC maintenance, but whether it is involved in the cross‐talk between CAFs and CICs to affect tumourigenesis and pathological significance has not been determined. In this study, we found that the presence of CAFs containing high levels of microtubule‐associated protein 1 light chain 3 (LC3II), a marker of autophagosomes, was associated with more aggressive luminal human breast cancer. CAFs in human luminal breast cancer tissues with high autophagy activity enriched BCICs with increased tumourigenicity. Mechanistically, autophagic CAFs released high‐mobility group box 1 (HMGB1), which activated its receptor, Toll‐like receptor (TLR) 4, expressed by luminal breast cancer cells, to enhance their stemness and tumourigenicity. Furthermore, immunohistochemistry of 180 luminal breast cancers revealed that high LC3II/TLR4 levels predicted an increased relapse rate and a poorer prognosis. Our findings demonstrate that autophagic CAFs play a critical role in promoting the progression of luminal breast cancer through an HMGB1–TLR4 axis, and that both autophagy in CAFs and TLR4 on breast cancer cells constitute potential therapeutic targets. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Cancer stem cells/cancer-initiating cells (CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis. Cancer-associated fibroblasts (CAFs) are major components of the niche of breast cancer-initiating cells (BCICs), and their interactions may profoundly affect breast cancer progression. Autophagy has been considered to be a critical process for CIC maintenance, but whether it is involved in the cross-talk between CAFs and CICs to affect tumourigenesis and pathological significance has not been determined. In this study, we found that the presence of CAFs containing high levels of microtubule-associated protein 1 light chain 3 (LC3II), a marker of autophagosomes, was associated with more aggressive luminal human breast cancer. CAFs in human luminal breast cancer tissues with high autophagy activity enriched BCICs with increased tumourigenicity. Mechanistically, autophagic CAFs released high-mobility group box 1 (HMGB1), which activated its receptor, Toll-like receptor (TLR) 4, expressed by luminal breast cancer cells, to enhance their stemness and tumourigenicity. Furthermore, immunohistochemistry of 180 luminal breast cancers revealed that high LC3II/TLR4 levels predicted an increased relapse rate and a poorer prognosis. Our findings demonstrate that autophagic CAFs play a critical role in promoting the progression of luminal breast cancer through an HMGB1–TLR4 axis, and that both autophagy in CAFs and TLR4 on breast cancer cells constitute potential therapeutic targets.
Cancer stem cells/cancer-initiating cells (CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis. Cancer-associated fibroblasts (CAFs) are major components of the niche of breast cancer-initiating cells (BCICs), and their interactions may profoundly affect breast cancer progression. Autophagy has been considered to be a critical process for CIC maintenance, but whether it is involved in the cross-talk between CAFs and CICs to affect tumourigenesis and pathological significance has not been determined. In this study, we found that the presence of CAFs containing high levels of microtubule-associated protein 1 light chain 3 (LC3II), a marker of autophagosomes, was associated with more aggressive luminal human breast cancer. CAFs in human luminal breast cancer tissues with high autophagy activity enriched BCICs with increased tumourigenicity. Mechanistically, autophagic CAFs released high-mobility group box 1 (HMGB1), which activated its receptor, Toll-like receptor (TLR) 4, expressed by luminal breast cancer cells, to enhance their stemness and tumourigenicity. Furthermore, immunohistochemistry of 180 luminal breast cancers revealed that high LC3II/TLR4 levels predicted an increased relapse rate and a poorer prognosis. Our findings demonstrate that autophagic CAFs play a critical role in promoting the progression of luminal breast cancer through an HMGB1-TLR4 axis, and that both autophagy in CAFs and TLR4 on breast cancer cells constitute potential therapeutic targets. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Cancer stem cells/cancer-initiating cells (CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis. Cancer-associated fibroblasts (CAFs) are major components of the niche of breast cancer-initiating cells (BCICs), and their interactions may profoundly affect breast cancer progression. Autophagy has been considered to be a critical process for CIC maintenance, but whether it is involved in the cross-talk between CAFs and CICs to affect tumourigenesis and pathological significance has not been determined. In this study, we found that the presence of CAFs containing high levels of microtubule-associated protein 1 light chain 3 (LC3II), a marker of autophagosomes, was associated with more aggressive luminal human breast cancer. CAFs in human luminal breast cancer tissues with high autophagy activity enriched BCICs with increased tumourigenicity. Mechanistically, autophagic CAFs released high-mobility group box 1 (HMGB1), which activated its receptor, Toll-like receptor (TLR) 4, expressed by luminal breast cancer cells, to enhance their stemness and tumourigenicity. Furthermore, immunohistochemistry of 180 luminal breast cancers revealed that high LC3II/TLR4 levels predicted an increased relapse rate and a poorer prognosis. Our findings demonstrate that autophagic CAFs play a critical role in promoting the progression of luminal breast cancer through an HMGB1-TLR4 axis, and that both autophagy in CAFs and TLR4 on breast cancer cells constitute potential therapeutic targets. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Author Fu, Wen‐Juan
Zhao, Xi‐Long
Bian, Xiu‐Wu
Niu, Qin
Lin, Yong
Liang, Yan
Tan, Jiao
Wang, Ji Ming
Zhang, Xia
Tang, Zhuo
Hu, Xu‐Gang
Guo, De‐Yu
Yan, Ze‐Xuan
Lu, Lu
Kung, Hsiang‐Fu
Yang, Shuai
Liu, Xue
Yao, Xiao‐Hong
Ping, Yi‐Fang
Jiang, Jun
AuthorAffiliation 1 Institute of Pathology and Southwest Cancer Centre, Southwest Hospital, Third Military Medical University, Chongqing, PR China
2 Breast Disease Centre, Southwest Hospital, Third Military Medical University, Chongqing, PR China
3 Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA
AuthorAffiliation_xml – name: 2 Breast Disease Centre, Southwest Hospital, Third Military Medical University, Chongqing, PR China
– name: 3 Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA
– name: 1 Institute of Pathology and Southwest Cancer Centre, Southwest Hospital, Third Military Medical University, Chongqing, PR China
Author_xml – sequence: 1
  givenname: Xi‐Long
  surname: Zhao
  fullname: Zhao, Xi‐Long
  organization: Southwest Hospital, Third Military Medical University
– sequence: 2
  givenname: Yong
  surname: Lin
  fullname: Lin, Yong
  organization: Southwest Hospital, Third Military Medical University
– sequence: 3
  givenname: Jun
  surname: Jiang
  fullname: Jiang, Jun
  organization: Southwest Hospital, Third Military Medical University
– sequence: 4
  givenname: Zhuo
  surname: Tang
  fullname: Tang, Zhuo
  organization: Southwest Hospital, Third Military Medical University
– sequence: 5
  givenname: Shuai
  surname: Yang
  fullname: Yang, Shuai
  organization: Southwest Hospital, Third Military Medical University
– sequence: 6
  givenname: Lu
  surname: Lu
  fullname: Lu, Lu
  organization: Southwest Hospital, Third Military Medical University
– sequence: 7
  givenname: Yan
  surname: Liang
  fullname: Liang, Yan
  organization: Southwest Hospital, Third Military Medical University
– sequence: 8
  givenname: Xue
  surname: Liu
  fullname: Liu, Xue
  organization: Southwest Hospital, Third Military Medical University
– sequence: 9
  givenname: Jiao
  surname: Tan
  fullname: Tan, Jiao
  organization: Southwest Hospital, Third Military Medical University
– sequence: 10
  givenname: Xu‐Gang
  surname: Hu
  fullname: Hu, Xu‐Gang
  organization: Southwest Hospital, Third Military Medical University
– sequence: 11
  givenname: Qin
  surname: Niu
  fullname: Niu, Qin
  organization: Southwest Hospital, Third Military Medical University
– sequence: 12
  givenname: Wen‐Juan
  surname: Fu
  fullname: Fu, Wen‐Juan
  organization: Southwest Hospital, Third Military Medical University
– sequence: 13
  givenname: Ze‐Xuan
  surname: Yan
  fullname: Yan, Ze‐Xuan
  organization: Southwest Hospital, Third Military Medical University
– sequence: 14
  givenname: De‐Yu
  surname: Guo
  fullname: Guo, De‐Yu
  organization: Southwest Hospital, Third Military Medical University
– sequence: 15
  givenname: Yi‐Fang
  surname: Ping
  fullname: Ping, Yi‐Fang
  organization: Southwest Hospital, Third Military Medical University
– sequence: 16
  givenname: Ji Ming
  surname: Wang
  fullname: Wang, Ji Ming
  organization: National Cancer Institute at Frederick
– sequence: 17
  givenname: Xia
  surname: Zhang
  fullname: Zhang, Xia
  organization: Southwest Hospital, Third Military Medical University
– sequence: 18
  givenname: Hsiang‐Fu
  surname: Kung
  fullname: Kung, Hsiang‐Fu
  email: hfkung@163.com
  organization: Southwest Hospital, Third Military Medical University
– sequence: 19
  givenname: Xiu‐Wu
  orcidid: 0000-0003-4383-0197
  surname: Bian
  fullname: Bian, Xiu‐Wu
  email: bianxiuwu@263.net
  organization: Southwest Hospital, Third Military Medical University
– sequence: 20
  givenname: Xiao‐Hong
  surname: Yao
  fullname: Yao, Xiao‐Hong
  email: yxh15@hotmail.com
  organization: Southwest Hospital, Third Military Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28802057$$D View this record in MEDLINE/PubMed
BookMark eNp9ksFuFSEUhompsbfVhS9gSNzoYlpghgtsTJrGek2a6KKuCcMwd2gYGIGp3p1Ll31Gn0TGXhttogvC4nzn5z-H_wgc-OANAM8xOsEIkdNJ5eGkEZQ_AiuMxLoSXKwPwKrUSFU3mB2Co5SuEUJCUPoEHBLOEUGUrcD3jd0OP77djqG1zuYd3MYwT7ANXyGG0Tijkulgu4NqzmEa1NZqqJXXJpYmlVLQVuVC9LaNoXUq5QRHZX0uJ8E8GJiyGb1JCYYeunm0XjnYxqKb90JQG-fSU_C4Vy6ZZ_v7GHy6eHt1vqkuP7x7f352WWmKBK96wupOa4101_e1QOuG18gIwjBmzAjBu5p3jOKWUkMoJUr1uqGUUy6I6PW6PgZv7nSnuR1Np43PUTk5RTuquJNBWfl3xdtBbsON5JjhRrAi8GovEMPn2aQsR5uWEZQ3YU4SC8IpLm-igr58gF6HOZYFLFRhECsOC_XiT0f3Vn5_UgFe3wE6hpSi6e8RjOQSALkEQC4BKOzpA1bbrLINyzDW_a_ji3Vm929p-fHsavOr4yfvI8b2
CitedBy_id crossref_primary_10_1016_j_ebiom_2018_12_016
crossref_primary_10_1002_jcp_31278
crossref_primary_10_1016_j_bbadis_2022_166484
crossref_primary_10_1007_s10555_018_9768_3
crossref_primary_10_3390_cancers12123863
crossref_primary_10_1007_s00280_020_04222_w
crossref_primary_10_1002_jcb_29473
crossref_primary_10_3390_cancers10110406
crossref_primary_10_1038_s41571_018_0007_1
crossref_primary_10_1002_mco2_549
crossref_primary_10_3389_fcell_2021_775462
crossref_primary_10_1002_kjm2_12299
crossref_primary_10_1016_j_senol_2021_08_003
crossref_primary_10_1016_j_semcancer_2018_08_002
crossref_primary_10_1038_s41575_020_0326_4
crossref_primary_10_3389_fonc_2020_01533
crossref_primary_10_3390_cancers13194756
crossref_primary_10_1002_cam4_2939
crossref_primary_10_1002_mco2_342
crossref_primary_10_1016_j_bbcan_2024_189105
crossref_primary_10_1186_s12964_020_00598_7
crossref_primary_10_1016_j_bbcan_2020_188416
crossref_primary_10_3390_ijms20010085
crossref_primary_10_1186_s13045_021_01087_1
crossref_primary_10_1186_s12935_022_02599_7
crossref_primary_10_18632_oncotarget_22161
crossref_primary_10_1016_j_biopha_2023_115425
crossref_primary_10_3389_fonc_2019_00820
crossref_primary_10_1016_j_bbcan_2023_189012
crossref_primary_10_1002_jcp_30419
crossref_primary_10_1002_jev2_70055
crossref_primary_10_1080_15548627_2019_1569947
crossref_primary_10_1177_1010428318756203
crossref_primary_10_1007_s13402_021_00634_9
crossref_primary_10_1016_j_soc_2019_02_010
crossref_primary_10_1038_s41419_018_0458_4
crossref_primary_10_3390_ijms222111636
crossref_primary_10_3892_br_2017_1034
crossref_primary_10_1038_s41598_020_75541_4
crossref_primary_10_1016_j_gendis_2023_05_024
crossref_primary_10_3390_diagnostics13121999
crossref_primary_10_1111_jcmm_13676
crossref_primary_10_1016_j_biopha_2023_114762
crossref_primary_10_1186_s13046_022_02291_8
crossref_primary_10_3390_cancers14010020
crossref_primary_10_1002_path_5189
crossref_primary_10_1016_j_rvsc_2024_105438
crossref_primary_10_1080_27694127_2024_2358648
crossref_primary_10_3389_fonc_2019_01104
crossref_primary_10_1016_j_canlet_2020_06_015
crossref_primary_10_1080_15548627_2019_1596479
crossref_primary_10_3389_or_2024_1507942
crossref_primary_10_3390_ijms21114158
crossref_primary_10_3390_ijms232012469
crossref_primary_10_3389_fphar_2018_00878
crossref_primary_10_3389_fcell_2021_727640
crossref_primary_10_1016_j_semcancer_2019_08_026
crossref_primary_10_3389_fonc_2024_1384109
crossref_primary_10_1038_s41419_019_1956_8
crossref_primary_10_3389_fonc_2020_606436
crossref_primary_10_3390_cancers12102896
crossref_primary_10_1038_s41392_021_00641_0
crossref_primary_10_3390_ijms21010254
crossref_primary_10_1039_C8TB03165G
crossref_primary_10_1186_s12964_020_00619_5
crossref_primary_10_1007_s12282_018_00935_2
crossref_primary_10_1038_s41598_018_21416_8
crossref_primary_10_1038_s41388_019_0765_y
crossref_primary_10_1002_slct_201800629
crossref_primary_10_1016_j_intimp_2024_113068
crossref_primary_10_3389_fcell_2021_620883
crossref_primary_10_1021_acsami_0c18545
crossref_primary_10_1038_s41556_018_0042_2
crossref_primary_10_1016_j_pharmthera_2019_04_004
crossref_primary_10_1042_EBC20170025
crossref_primary_10_1016_j_biopha_2022_113757
crossref_primary_10_1080_15384047_2019_1591122
crossref_primary_10_1186_s13046_019_1172_5
crossref_primary_10_1210_endrev_bnad005
crossref_primary_10_1016_j_isci_2022_104872
crossref_primary_10_1155_2021_8840066
crossref_primary_10_1038_s41419_021_04150_4
crossref_primary_10_1038_s43018_022_00426_6
crossref_primary_10_1186_s12943_022_01682_x
Cites_doi 10.1016/j.devcel.2010.05.012
10.1371/journal.pmed.1000010
10.4161/cc.20718
10.1002/path.2694
10.1158/0008-5472.CAN-11-3567
10.4161/15548627.2014.981788
10.1016/j.cell.2008.03.027
10.1186/bcr2231
10.1038/onc.2012.252
10.6026/97320630081147
10.1158/0008-5472.CAN-13-2563
10.1038/ncomms4472
10.1083/jcb.200911078
10.4161/auto.23997
10.1038/nrc3262
10.1097/CJI.0b013e31804efc76
10.1016/j.chembiol.2007.03.007
10.1016/j.stem.2007.08.014
10.1038/onc.2013.527
10.1126/stke.2002.151.pe39
10.1158/0008-5472.CAN-08-2741
10.1158/0008-5472.CAN-13-3536
10.1038/nrc3240
10.1016/j.neuint.2014.05.007
10.1111/j.1349-7006.2011.02183.x
10.1038/nature10694
10.1016/j.tcb.2012.04.008
10.1101/gad.1061803
10.1124/jpet.111.182592
10.1038/ni1457
10.1038/nrc2618
10.1093/emboj/20.16.4337
10.1038/onc.2012.111
10.1242/jcs.103630
10.1097/01.shk.0000225404.51320.82
10.1016/j.ajpath.2011.05.059
10.1126/science.1234740
10.1016/j.coi.2008.04.012
10.1016/S1470-2045(11)70257-1
10.1073/pnas.191367098
10.1038/nrm2617
10.7150/jca.10890
10.1093/annonc/mdr304
10.1002/stem.1031
10.1111/j.1600-065X.2007.00573.x
10.1002/jcp.24347
10.1124/mol.110.068064
10.1016/j.stem.2015.02.015
10.1038/35102167
ContentType Journal Article
Copyright Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Copyright © 2017 Pathological Society of Great Britain and Ireland
Copyright_xml – notice: Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
– notice: Copyright © 2017 Pathological Society of Great Britain and Ireland
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7T5
7TK
7TM
7TO
8FD
FR3
H94
K9.
P64
RC3
7X8
5PM
DOI 10.1002/path.4958
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Chemoreception Abstracts
Immunology Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef


Genetics Abstracts
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1096-9896
EndPage 389
ExternalDocumentID PMC8171497
28802057
10_1002_path_4958
PATH4958
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United Kingdom--UK
Ireland
GeographicLocations_xml – name: Ireland
– name: United Kingdom--UK
GrantInformation_xml – fundername: National Natural Science Foundation of China
  funderid: 81372684; 81230062
– fundername: National Key Research and Development Programme of China Stem Cell and Translational Research
  funderid: 2016YFA0101203
– fundername: Key Laboratory of Tumour Immunopathology, Ministry of Education of China
  funderid: 2015jszl07
– fundername: Intramural NIH HHS
  grantid: Z01 BC010015
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
123
1KJ
1L6
1OB
1OC
1ZS
29L
31~
33P
3O-
3SF
3UE
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AI.
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
GSXLS
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
J5H
JPC
KBYEO
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M68
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MVM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OHT
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
SAMSI
SUPJJ
SV3
TEORI
UB1
V2E
VH1
W8V
W99
WBKPD
WH7
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
XPP
XV2
YQI
YQJ
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7T5
7TK
7TM
7TO
8FD
FR3
H94
K9.
P64
RC3
7X8
5PM
ID FETCH-LOGICAL-c5098-f273dccc0cdff39064830e9271177e998d38d751b55e2552aafc455858929fc63
IEDL.DBID DR2
ISSN 0022-3417
1096-9896
IngestDate Thu Aug 21 14:04:44 EDT 2025
Thu Jul 10 17:46:42 EDT 2025
Fri Jul 25 12:29:08 EDT 2025
Mon Jul 21 05:51:08 EDT 2025
Tue Jul 01 04:21:16 EDT 2025
Thu Apr 24 23:04:08 EDT 2025
Wed Jan 22 16:52:37 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords high-mobility group box 1 (HMGB1)
breast cancer-initiating cell (BCIC)
Toll-like receptor 4 (TLR4)
autophagy
cancer-associated fibroblast (CAF)
Language English
License Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5098-f273dccc0cdff39064830e9271177e998d38d751b55e2552aafc455858929fc63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
The authors contributed in the following way: X-LZ, YL: performed most of the experiments and wrote the manuscript; LL, SY: performed the lentivirus and adenovirus infection; XL, JJ, YL, TJ: collected the clinical specimens; X-GH, Z-XY, QN: prepared the reagents; W-JF: performed the western blotting; X-HY, Y-FP, D-YG: performed the immunohistochemical scoring; X-HY, X-WB: performed data analysis; J-MW, XZ: edited and revised the manuscript; X-HY, H-FK, X-WB: designed the study, revised the manuscript, and provided administrative management.
Author contributions statement
ORCID 0000-0003-4383-0197
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/8171497
PMID 28802057
PQID 1951407552
PQPubID 1006392
PageCount 14
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8171497
proquest_miscellaneous_1928514550
proquest_journals_1951407552
pubmed_primary_28802057
crossref_primary_10_1002_path_4958
crossref_citationtrail_10_1002_path_4958
wiley_primary_10_1002_path_4958_PATH4958
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2017
PublicationDateYYYYMMDD 2017-11-01
PublicationDate_xml – month: 11
  year: 2017
  text: November 2017
PublicationDecade 2010
PublicationPlace Chichester, UK
PublicationPlace_xml – name: Chichester, UK
– name: England
– name: Bognor Regis
PublicationTitle The Journal of pathology
PublicationTitleAlternate J Pathol
PublicationYear 2017
Publisher John Wiley & Sons, Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Ltd
– name: Wiley Subscription Services, Inc
References 2015; 34
2010; 18
2007; 220
2010; 221
2003; 17
2007; 30
2012; 125
2012; 13
2012; 12
2012; 11
2013; 9
2012; 72
2002; 2002
2009; 11
2014; 5
2009; 10
2001
1986; 46
2006; 26
2007; 8
2011; 22
2008; 20
2010; 190
2011; 481
2007; 1
2014; 50
2012; 22
2014; 10
2001; 98
2009; 69
2011; 179
2015; 6
2011; 339
2015; 16
2013; 228
2000; 747—752
2011; 79
2013; 340
2012; 103
2007; 14
2012; 30
2001; 20
2013; 32
2009; 9
2009; 6
2014; 74
2008; 133
2012; 8
2014; 75
e_1_2_7_5_1
e_1_2_7_9_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_17_1
e_1_2_7_15_1
e_1_2_7_41_1
e_1_2_7_13_1
e_1_2_7_43_1
e_1_2_7_11_1
e_1_2_7_45_1
e_1_2_7_47_1
e_1_2_7_26_1
e_1_2_7_49_1
e_1_2_7_28_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_52_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_21_1
e_1_2_7_35_1
e_1_2_7_37_1
e_1_2_7_39_1
Perou CM (e_1_2_7_50_1) 2000; 747
e_1_2_7_6_1
Antoniou A (e_1_2_7_3_1) 2014; 50
e_1_2_7_4_1
e_1_2_7_8_1
e_1_2_7_18_1
e_1_2_7_16_1
e_1_2_7_40_1
e_1_2_7_2_1
e_1_2_7_14_1
e_1_2_7_42_1
Naito S (e_1_2_7_29_1) 1986; 46
e_1_2_7_12_1
e_1_2_7_44_1
e_1_2_7_10_1
e_1_2_7_46_1
e_1_2_7_48_1
e_1_2_7_27_1
e_1_2_7_51_1
e_1_2_7_30_1
e_1_2_7_53_1
e_1_2_7_24_1
e_1_2_7_32_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_20_1
e_1_2_7_36_1
e_1_2_7_38_1
References_xml – volume: 72
  start-page: 2768
  year: 2012
  end-page: 2779
  article-title: CCL2 mediates cross‐talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells
  publication-title: Cancer Res
– volume: 179
  start-page: 1504
  year: 2011
  end-page: 1512
  article-title: Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1
  publication-title: Am J Pathol
– volume: 8
  start-page: 1147
  year: 2012
  end-page: 1153
  article-title: Structural insight into the ligand–receptor interaction between glycyrrhetinic acid (GA) and the high‐mobility group protein B1 (HMGB1)–DNA complex
  publication-title: Bioinformation
– volume: 12
  start-page: 152
  year: 2012
  article-title: Enforced compliance
  publication-title: Nat Rev Cancer
– volume: 14
  start-page: 431
  year: 2007
  end-page: 441
  article-title: Glycyrrhizin binds to high‐mobility group box 1 protein and inhibits its cytokine activities
  publication-title: Chem Biol
– volume: 74
  start-page: 2487
  year: 2014
  end-page: 2498
  article-title: Curcumin promotes autophagic survival of a subset of colon cancer stem cells, which are ablated by DCLK1‐siRNA
  publication-title: Cancer Res
– volume: 1
  start-page: 555
  year: 2007
  end-page: 567
  article-title: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
  publication-title: Cell Stem Cell
– volume: 6
  start-page: 1331
  year: 2015
  end-page: 1336
  article-title: Low dose, low cost estradiol pellets can support MCF‐7 tumour growth in nude mice without bladder symptoms
  publication-title: J Cancer
– volume: 32
  start-page: 699
  year: 2013
  end-page: 712
  article-title: The autophagy‐associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells
  publication-title: Oncogene
– volume: 22
  start-page: 397
  year: 2012
  end-page: 406
  article-title: Autophagy intersections with conventional and unconventional secretion in tissue development, remodeling and inflammation
  publication-title: Trends Cell Biol
– volume: 228
  start-page: 1651
  year: 2013
  end-page: 1657
  article-title: Carcinoma‐associated fibroblasts: non‐neoplastic tumour‐promoting mesenchymal cells
  publication-title: J Cell Physiol
– volume: 340
  start-page: 559
  year: 2013
  end-page: 561
  article-title: Cell biology. Unconventional secretion, unconventional solutions
  publication-title: Science
– volume: 16
  start-page: 225
  year: 2015
  end-page: 238
  article-title: The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?
  publication-title: Cell Stem Cell
– volume: 50
  start-page: 3743
  year: 2014
  end-page: 3748
  article-title: Cancer stem cells, a fuzzy evolving concept: a cell population or a cell property?
  publication-title: Cell Cycle
– volume: 26
  start-page: 174
  year: 2006
  end-page: 179
  article-title: HMGB1 signals through toll‐like receptor (TLR) 4 and TLR2
  publication-title: Shock
– volume: 34
  start-page: 27
  year: 2015
  end-page: 38
  article-title: TGF‐beta receptor type‐2 expression in cancer‐associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre‐menopausal breast cancer
  publication-title: Oncogene
– volume: 10
  start-page: 148
  year: 2009
  end-page: 155
  article-title: Mechanisms of regulated unconventional protein secretion
  publication-title: Nat Rev Mol Cell Biol
– volume: 11
  start-page: 2285
  year: 2012
  end-page: 2302
  article-title: Autophagy and senescence in cancer‐associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production
  publication-title: Cell Cycle
– volume: 98
  start-page: 10869
  year: 2001
  end-page: 10874
  article-title: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
  publication-title: Proc Natl Acad Sci U S A
– volume: 79
  start-page: 34
  year: 2011
  end-page: 41
  article-title: TAK‐242 (resatorvid), a small‐molecule inhibitor of Toll‐like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules
  publication-title: Mol Pharmacol
– volume: 5
  start-page: 3472
  year: 2014
  article-title: Cancer‐associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling
  publication-title: Nat Commun
– volume: 220
  start-page: 47
  year: 2007
  end-page: 59
  article-title: The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
  publication-title: Immunol Rev
– volume: 8
  start-page: 487
  year: 2007
  end-page: 496
  article-title: Toll‐like receptor 9‐dependent activation by DNA‐containing immune complexes is mediated by HMGB1 and RAGE
  publication-title: Nat Immunol
– volume: 103
  start-page: 400
  year: 2012
  end-page: 407
  article-title: Interactions between tumor cells and microenvironment in breast cancer: a new opportunity for targeted therapy
  publication-title: Cancer Sci
– volume: 9
  start-page: 239
  year: 2009
  end-page: 252
  article-title: Microenvironmental regulation of metastasis
  publication-title: Nat Rev Cancer
– volume: 17
  start-page: 1253
  year: 2003
  end-page: 1270
  article-title: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
  publication-title: Genes Dev
– volume: 20
  start-page: 518
  year: 2008
  end-page: 523
  article-title: HMGB1: a two‐headed signal regulating tumor progression and immunity
  publication-title: Curr Opin Immunol
– volume: 46
  start-page: 4109
  year: 1986
  end-page: 4115
  article-title: Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice
  publication-title: Cancer Res
– volume: 20
  start-page: 4337
  year: 2001
  end-page: 4340
  article-title: New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal
  publication-title: EMBO J
– volume: 18
  start-page: 884
  year: 2010
  end-page: 901
  article-title: Tumors as organs: complex tissues that interface with the entire organism
  publication-title: Dev Cell
– volume: 2002
  start-page: pe39
  year: 2002
  article-title: At the crossroads of necrosis and apoptosis: signaling to multiple cellular targets by HMGB1
  publication-title: Sci STKE
– volume: 11
  start-page: R12
  year: 2009
  article-title: Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells
  publication-title: Breast Cancer Res
– volume: 133
  start-page: 704
  year: 2008
  end-page: 715
  article-title: The epithelial–mesenchymal transition generates cells with properties of stem cells
  publication-title: Cell
– start-page: 105
  year: 2001
  end-page: 111
  article-title: Stem cells, cancer, and cancer stem cells
  publication-title: Nature
– volume: 339
  start-page: 93
  year: 2011
  end-page: 98
  article-title: Glycyrrhizin prevents liver injury by inhibition of high‐mobility group box 1 production by Kupffer cells after ischemia–reperfusion in rats
  publication-title: J Pharmacol Exp Ther
– volume: 12
  start-page: 401
  year: 2012
  end-page: 410
  article-title: Deconvoluting the context‐dependent role for autophagy in cancer
  publication-title: Nat Rev Cancer
– volume: 481
  start-page: 85
  year: 2011
  end-page: 89
  article-title: Interactions between cancer stem cells and their niche govern metastatic colonization
  publication-title: Nature
– volume: 69
  start-page: 1302
  year: 2009
  end-page: 1313
  article-title: Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature
  publication-title: Cancer Res
– volume: 32
  start-page: 2261
  year: 2013
  end-page: 2272
  article-title: Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem‐like/progenitor cells
  publication-title: Oncogene
– volume: 9
  start-page: 714
  year: 2013
  end-page: 729
  article-title: Inhibition of the autophagic flux by salinomycin in breast cancer stem‐like/progenitor cells interferes with their maintenance
  publication-title: Autophagy
– volume: 190
  start-page: 881
  year: 2010
  end-page: 892
  article-title: Endogenous HMGB1 regulates autophagy
  publication-title: J Cell Biol
– volume: 22
  start-page: 1736
  year: 2011
  end-page: 1747
  article-title: Strategies for subtypes – dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
  publication-title: Ann Oncol
– volume: 221
  start-page: 117
  year: 2010
  end-page: 124
  article-title: Autophagy: assays and artifacts
  publication-title: J Pathol
– volume: 75
  start-page: 32
  year: 2014
  end-page: 38
  article-title: High‐mobility group box 1 up‐regulates aquaporin 4 expression via microglia–astrocyte interaction
  publication-title: Neurochem Int
– volume: 125
  start-page: 5251
  year: 2012
  end-page: 5255
  article-title: Diversity in unconventional protein secretion
  publication-title: J Cell Sci
– volume: 74
  start-page: 5746
  year: 2014
  end-page: 5757
  article-title: Metastatic consequences of immune escape from NK cell cytotoxicity by human breast cancer stem cells
  publication-title: Cancer Res
– volume: 747—752
  start-page: 406
  year: 2000
  article-title: Molecular portraits of human breast tumours
  publication-title: Nature
– volume: 6
  year: 2009
  article-title: HMGB1 mediates endogenous TLR2 activation and brain tumor regression
  publication-title: PLoS Med
– volume: 30
  start-page: 596
  year: 2007
  end-page: 606
  article-title: High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy
  publication-title: J Immunother
– volume: 30
  start-page: 363
  year: 2012
  end-page: 371
  article-title: Colorectal cancer stem cells
  publication-title: Stem Cells
– volume: 10
  start-page: 2122
  year: 2014
  end-page: 2142
  article-title: Inhibition of autophagy as a new means of improving chemotherapy efficiency in high‐LC3B triple‐negative breast cancers
  publication-title: Autophagy
– volume: 13
  start-page: e83
  year: 2012
  end-page: e89
  article-title: The developing cancer stem‐cell model: clinical challenges and opportunities
  publication-title: Lancet Oncol
– ident: e_1_2_7_2_1
  doi: 10.1016/j.devcel.2010.05.012
– volume: 46
  start-page: 4109
  year: 1986
  ident: e_1_2_7_29_1
  article-title: Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice
  publication-title: Cancer Res
– ident: e_1_2_7_44_1
  doi: 10.1371/journal.pmed.1000010
– ident: e_1_2_7_23_1
  doi: 10.4161/cc.20718
– ident: e_1_2_7_30_1
  doi: 10.1002/path.2694
– ident: e_1_2_7_15_1
  doi: 10.1158/0008-5472.CAN-11-3567
– ident: e_1_2_7_19_1
  doi: 10.4161/15548627.2014.981788
– ident: e_1_2_7_26_1
  doi: 10.1016/j.cell.2008.03.027
– ident: e_1_2_7_39_1
  doi: 10.1186/bcr2231
– ident: e_1_2_7_16_1
  doi: 10.1038/onc.2012.252
– ident: e_1_2_7_35_1
  doi: 10.6026/97320630081147
– ident: e_1_2_7_27_1
  doi: 10.1158/0008-5472.CAN-13-2563
– ident: e_1_2_7_14_1
  doi: 10.1038/ncomms4472
– ident: e_1_2_7_42_1
  doi: 10.1083/jcb.200911078
– ident: e_1_2_7_17_1
  doi: 10.4161/auto.23997
– ident: e_1_2_7_37_1
  doi: 10.1038/nrc3262
– ident: e_1_2_7_48_1
  doi: 10.1097/CJI.0b013e31804efc76
– ident: e_1_2_7_33_1
  doi: 10.1016/j.chembiol.2007.03.007
– ident: e_1_2_7_11_1
  doi: 10.1016/j.stem.2007.08.014
– ident: e_1_2_7_12_1
  doi: 10.1038/onc.2013.527
– ident: e_1_2_7_49_1
  doi: 10.1126/stke.2002.151.pe39
– volume: 50
  start-page: 3743
  year: 2014
  ident: e_1_2_7_3_1
  article-title: Cancer stem cells, a fuzzy evolving concept: a cell population or a cell property?
  publication-title: Cell Cycle
– ident: e_1_2_7_10_1
  doi: 10.1158/0008-5472.CAN-08-2741
– ident: e_1_2_7_38_1
  doi: 10.1158/0008-5472.CAN-13-3536
– ident: e_1_2_7_6_1
  doi: 10.1038/nrc3240
– ident: e_1_2_7_32_1
  doi: 10.1016/j.neuint.2014.05.007
– ident: e_1_2_7_7_1
  doi: 10.1111/j.1349-7006.2011.02183.x
– ident: e_1_2_7_9_1
  doi: 10.1038/nature10694
– ident: e_1_2_7_20_1
  doi: 10.1016/j.tcb.2012.04.008
– ident: e_1_2_7_25_1
  doi: 10.1101/gad.1061803
– ident: e_1_2_7_34_1
  doi: 10.1124/jpet.111.182592
– ident: e_1_2_7_46_1
  doi: 10.1038/ni1457
– ident: e_1_2_7_4_1
  doi: 10.1038/nrc2618
– ident: e_1_2_7_31_1
  doi: 10.1093/emboj/20.16.4337
– ident: e_1_2_7_18_1
  doi: 10.1038/onc.2012.111
– ident: e_1_2_7_41_1
  doi: 10.1242/jcs.103630
– ident: e_1_2_7_45_1
  doi: 10.1097/01.shk.0000225404.51320.82
– ident: e_1_2_7_28_1
  doi: 10.1016/j.ajpath.2011.05.059
– ident: e_1_2_7_22_1
  doi: 10.1126/science.1234740
– ident: e_1_2_7_47_1
  doi: 10.1016/j.coi.2008.04.012
– ident: e_1_2_7_53_1
  doi: 10.1016/S1470-2045(11)70257-1
– ident: e_1_2_7_51_1
  doi: 10.1073/pnas.191367098
– ident: e_1_2_7_21_1
  doi: 10.1038/nrm2617
– ident: e_1_2_7_40_1
  doi: 10.7150/jca.10890
– ident: e_1_2_7_24_1
  doi: 10.1093/annonc/mdr304
– ident: e_1_2_7_8_1
  doi: 10.1002/stem.1031
– ident: e_1_2_7_43_1
  doi: 10.1111/j.1600-065X.2007.00573.x
– ident: e_1_2_7_13_1
  doi: 10.1002/jcp.24347
– ident: e_1_2_7_36_1
  doi: 10.1124/mol.110.068064
– volume: 747
  start-page: 406
  year: 2000
  ident: e_1_2_7_50_1
  article-title: Molecular portraits of human breast tumours
  publication-title: Nature
– ident: e_1_2_7_52_1
  doi: 10.1016/j.stem.2015.02.015
– ident: e_1_2_7_5_1
  doi: 10.1038/35102167
SSID ssj0009955
Score 2.5298977
Snippet Cancer stem cells/cancer‐initiating cells (CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis....
Cancer stem cells/cancer-initiating cells (CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis....
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 376
SubjectTerms Aged
Aged, 80 and over
Autophagy
Breast cancer
breast cancer‐initiating cell (BCIC)
Breast Neoplasms - metabolism
Breast Neoplasms - pathology
Cancer-Associated Fibroblasts - metabolism
Cancer-Associated Fibroblasts - pathology
cancer‐associated fibroblast (CAF)
Cell Line, Tumor
Cell Transformation, Neoplastic - metabolism
Cell Transformation, Neoplastic - pathology
Female
Fibroblasts
high‐mobility group box 1 (HMGB1)
HMGB1 protein
HMGB1 Protein - metabolism
Humans
Immunohistochemistry
Metastases
Microtubule-associated protein 1
Microtubule-Associated Proteins - metabolism
Middle Aged
Mobility
Neoplasm Recurrence, Local - metabolism
Neoplasm Recurrence, Local - pathology
Neoplastic Stem Cells - metabolism
Neoplastic Stem Cells - pathology
Phagocytosis
Phagosomes
Stem cells
TLR4 protein
Toll-Like Receptor 4 - metabolism
Toll-like receptors
Toll‐like receptor 4 (TLR4)
Tumor Microenvironment - physiology
Tumorigenesis
Tumors
Title High‐mobility group box 1 released by autophagic cancer‐associated fibroblasts maintains the stemness of luminal breast cancer cells
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpath.4958
https://www.ncbi.nlm.nih.gov/pubmed/28802057
https://www.proquest.com/docview/1951407552
https://www.proquest.com/docview/1928514550
https://pubmed.ncbi.nlm.nih.gov/PMC8171497
Volume 243
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hDhUX-uCVdlsZxIFLlsSO8xCnVVW0qgRCCCQOSJHtxAK1m1QkK5Weeuyxv7G_hJm86EKRUG8rZbzreGfG39gz3wDsqtzzFG4bbojbnRtEGLMSjZSLEXNguTIqtHQOeXQcTs-DzxfyYgkO-lqYlh9iOHAjy2j8NRm40tX-PWkodewdI7ynQl_K1SJAdHpPHZUkUg5M4YEf9axCHt8fRi7uRY8A5uM8yb_xa7MBHb6Ey37qbd7Jl_G81mPz4wGr43--2ytY7YApm7Sa9BqW8uINvDjqrt7X4BdlhPz5-XtWNum0t6ypB2G6_M58Rp1XcDvMmL5lak5cBQo9KjOkUjc4SHVKgBIWJ1ZqxOx1xWbquqCjiYohDGVEKU2Ol5WWocukdl1MU8583X0Ro1uGah3ODz-dfZy6XRsH10hiK7WIkDJjjGcya0WCGCgWXp7wiO6Lcwz3MhFnkfS1lDkGOFwpawKJYUyM0M2aUGzAclEW-RYwIVWohRdkKhEoEqowxojKJr6wXiAC48Be_4empuM4p1YbX9OWnZmntLIprawDO4Pot5bY419Co14r0s62q9RHUIphMM7Uge3hMVolLYIq8nJOMhyhLFWMO7DZKtHwKxxdJkeY7EC0oF6DADF-Lz4prq8a5u-Y2tUnOHKv0Z6nJ56eTM6m9OHt80XfwQonzNIUWo5gub6Z5-8RcdX6Q2NadwLdLI4
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LTxRBEK7gmggXHoo4CNIaD1xmmemenkfChahkBZYYsyRczKSnZzoSZcbszibAyaNHfyO_hKp54YokxNsmU73b01uPr7qrvwJ4qzLHURg2bB_Dne0FmLMSjZSNGbNnuNLKN7QPOTz2Byfewak8nYPd9i5MzQ_RbbiRZVT-mgycNqR3bllDqWVvH_F9-AgeU0dvYs5___mWPCqKpOy4wj03aHmFHL7TDZ2NRncg5t1KyT8RbBWC9pfgSzv5uvLkW39aJn199Rev4_--3TIsNtiU7dXKtAJzWf4Ungyb0_dn8IuKQq5__j4vqoraS1ZdCWFJccFcRs1XMCKmLLlkakp0BQqdKtOkVWMcpBo9QAmDMysShO3lhJ2rs5x2JyYMkSgjVmnyvawwDL0mdexiCZXNl80XMTpomKzCyf6H0buB3XRysLUkwlKDICnVWjs6NUZECINC4WQRD-jIOMOMLxVhGkg3kTLDHIcrZbQnMZMJEb0Z7Yvn0MuLPHsBTEjlJ8LxUhUJFPGVH2JSZSJXGMcTnrZgu_1HY93QnFO3je9xTdDMY1rZmFbWgjed6I-a2-NfQhutWsSNeU9iF3EpZsI4Uwted4_RMGkRVJ4VU5LhiGbp0rgFa7UWdb_C0WtyRMoWBDP61QkQ6ffsk_zsa0X-HVLH-ghHblfqc__E4097owF9WH-46BbMD0bDo_jo4_HhS1jgBGGqe5cb0CvH02wTAViZvKrs7AaYiDCq
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LTxRBEK4gJsSLIj4YQW2NBy6zzPRjHvFExM0KQoiBhIPJpKdnOhJkhrCzCXDiyJHf6C-hal6woAnxtslU7_b01uOr7uqvAD7p3PM0hg03wHDnyhBzVqKRcjFjlpZrowNL-5Bb28FoT27sq_0Z-NzdhWn4IfoNN7KM2l-TgR9ndvWGNJQ69g4Q3keP4LEMvJj6Nqz_uOGOimOleqpw6YcdrZDHV_uh08HoHsK8Xyh5G8DWEWj4DH52c28KTw4HkyodmPM7tI7_-XLz8LRFpmytUaXnMJMXCzC31Z69v4BLKgn5c3F1VNb1tGesvhDC0vKU-Yxar2A8zFh6xvSEyAo0ulRmSKdOcJButQAlLE6sTBG0V2N2pA8K2psYM8ShjDilyfOy0jL0mdSvi6VUNF-1X8TomGH8EvaGX3e_jNy2j4NrFNGVWoRImTHGM5m1IkYQFAkvj3lIB8Y55nuZiLJQ-alSOWY4XGtrpMI8JkLsZk0gXsFsURb5IjChdJAKT2Y6FigS6CDClMrGvrCeFNI4sNL9oYlpSc6p18bvpKFn5gmtbEIr68DHXvS4Yfb4m9BypxVJa9zjxEdUinkwztSBD_1jNEtaBF3k5YRkOGJZujLuwOtGifpf4egzOeJkB8Ip9eoFiPJ7-klx8Kum_o6oX32MI1dq7fn3xJOdtd0RfXjzcNH3MLezPky-f9veXIInnPBLfelyGWark0n-FtFXlb6rrewa9ZkvWQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High-mobility+group+box+1+released+by+autophagic+cancer-associated+fibroblasts+maintains+the+stemness+of+luminal+breast+cancer+cells&rft.jtitle=The+Journal+of+pathology&rft.au=Zhao%2C+Xi-Long&rft.au=Lin%2C+Yong&rft.au=Jiang%2C+Jun&rft.au=Tang%2C+Zhuo&rft.date=2017-11-01&rft.issn=0022-3417&rft.eissn=1096-9896&rft.volume=243&rft.issue=3&rft.spage=376&rft.epage=389&rft_id=info:doi/10.1002%2Fpath.4958&rft_id=info%3Apmid%2F28802057&rft.externalDocID=PMC8171497
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3417&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3417&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3417&client=summon